Skip to search formSkip to main contentSkip to account menu

mebudipine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Abstract A nanoemulsion drug delivery system was developed to increase the oral bioavailability of mebudipine as a calcium… 
2012
2012
Background: Myocardial infarction (MI) is the acute condition of necrosis in myocardium which occurs as a result of imbalance… 
2011
2011
Objectives Previous studies have suggested that failure of the synthesis of nitric oxide is involved in the pathophysiology of… 
2010
2010
A number of known 1,4-dihydropyridine CCBs were identified as having comparable potency to the steroidal MR antagonist eplerenone… 
2007
2007
Mebudipine and dibudipine are two newly synthesized dihydropyridine (DHP) calcium channel blockers that have been shown to have… 
2004
2004
The prototype 1,4‐dihydropyridine (1,4‐DHP) nifedipine, indicated for the management of hypertension and angina pectoris, has… 
2003
2003
Mebudipine and dibudipine are two new dihydropyridine (DHP) Ca2+ channel blockers that have been synthesized by Mahmoudian et al… 
2001
2001
PURPOSE To develop a high performance liquid chromatography system for the determination of a new 1,4-dihydropyridine, mebudipine… 
1999
1999
Mebudipine and dibudipine are two new dihydropyridine calcium‐channel blockers that have been synthesized in our laboratory. In a… 
1997
1997
Dihydropyridine derivative calcium‐channel blockers are widely used in the therapy of hypertension, angina pectoris and other…